39 Result(s)

Article

Association of physical activity with all-cause mortality and incident and prevalent cardiovascular disease among patients with type 1 diabetes: the EURODIAB Prospective Complications Study

The aim of this study was to examine the association of physical activity (PA) with all-cause mortality and incident and prevalent cardiovascular disease (CVD) among patients with type 1 diabetes.

S. M. A. J. Tielemans, S. S. Soedamah-Muthu, M. De Neve, M. Toeller… in Diabetologia (2013)

Article

Dietary saturated fat and fibre and risk of cardiovascular disease and all-cause mortality among type 1 diabetic patients: the EURODIAB Prospective Complications Study

Low adherence to recommendations for dietary saturated fatty acid (SFA) and fibre intake in patients with type 1 diabetes mellitus may heighten their increased risk of cardiovascular disease (CVD) and mortalit...

D. A. J. M. Schoenaker, M. Toeller, N. Chaturvedi, J. H. Fuller… in Diabetologia (2012)

Article

Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled diabetic retinopathy candesartan trials

The teratogenic consequences of angiotensin-converting enzyme inhibitors angiotensin receptor blockers (ARBs) during the second and third trimesters of pregnancy are well described. However, the consequences o...

M. Porta, J. W. Hainer, S.-O. Jansson, A. Malm, R. Bilous, N. Chaturvedi… in Diabetologia (2011)

Article

Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction rule

Microalbuminuria is common in type 1 diabetes and is associated with an increased risk of renal and cardiovascular disease. We aimed to develop and validate a clinical prediction rule that estimates the absolu...

Y. Vergouwe, S. S. Soedamah-Muthu, J. Zgibor, N. Chaturvedi, C. Forsblom… in Diabetologia (2010)

Article

Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospective Complications Study

Plasma soluble receptor for AGE (sRAGE) may reflect the activity of the AGE–RAGE axis, which has been proposed as a potential mechanism linking hyperglycaemia to vascular complications in diabetes. We have the...

J. W. M. Nin, I. Ferreira, C. G. Schalkwijk, M. H. Prins, N. Chaturvedi… in Diabetologia (2009)

Article

Alcohol consumption and risk of microvascular complications in type 1 diabetes patients: the EURODIAB Prospective Complications Study

The aim of this study was to investigate the association between alcohol consumption and risk of microvascular complications (retinopathy, neuropathy, nephropathy) in type 1 diabetes mellitus patients in the E...

J. W. J. Beulens, J. S. Kruidhof, D. E. Grobbee, N. Chaturvedi… in Diabetologia (2008)

Article

Relationship between plasma sialic acid and fibrinogen concentration and incident micro- and macrovascular complications in type 1 diabetes. The EURODIAB Prospective Complications Study (PCS)

Type 1 diabetes is associated with an increased risk of vascular complications. This increased risk could be explained by sialic acid and/or fibrinogen. It is also not clear what explains the abolition of sex-...

S. S. Soedamah-Muthu, N. Chaturvedi, J. C. Pickup, J. H. Fuller in Diabetologia (2008)

Article

Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS)

We estimated the cost-effectiveness of atorvastatin treatment in the primary prevention of cardiovascular disease in patients with type 2 diabetes using data from the Collaborative Atorvastatin Diabetes Study ...

M. Raikou, A. McGuire, H. M. Colhoun, D. J. Betteridge, P. N. Durrington… in Diabetologia (2007)

Article

All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992–1999

We compiled up to date estimates of the absolute and relative risk of all-cause mortality in patients with type 1 diabetes in the UK.

S. S. Soedamah-Muthu, J. H. Fuller, H. E. Mulnier, V. S. Raleigh… in Diabetologia (2006)

Article

Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS)

The aim of this study was to determine the pattern of the effect of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor atorvastatin on cardiovascular events in patients with type 2 diabetes and no p...

H. M. Colhoun, D. J. Betteridge, P. N. Durrington, G. A. Hitman… in Diabetologia (2005)

Article

Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes—the EURODIAB Prospective Complications Study

The pathogenesis of vascular complications in type 1 diabetes is poorly understood, but may involve chronic, low-grade inflammation. We investigated the association of markers of inflammation with vascular com...

M. T. Schram, N. Chaturvedi, C. G. Schalkwijk, J. H. Fuller… in Diabetologia (2005)

Article

Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus

Cardiac autonomic neuropathy (CAN) is associated with increased morbidity and mortality in type 1 diabetes. Apart from glycaemic control, risk factors for CAN have not been extensively studied.

D. R. Witte, S. Tesfaye, N. Chaturvedi, S. E. M. Eaton, P. Kempler… in Diabetologia (2005)

Article

40^th EASD Annual Meeting of the European Association for the Study of Diabetes

M. Veitenhansl, K. Stegner, F.-X. Hierl, C. Dieterle, H. Feldmeier, B. Gutt… in Diabetologia (2004)

Article

Trends in hypertension management in Type I diabetes across Europe, 1989/1990 – 1997/1999

S. S. Soedamah-Muthu, H. M. Colhoun, H. Abrahamian, N. N. Chan, R. Mangili… in Diabetologia (2003)

Article

Trends in hypertension management in Type I diabetes across Europe, 1989/1990 – 1997/1999

Our aim was to examine the change in the management of hypertension in patients with Type I (insulin-dependent) diabetes mellitus in Europe, between 1989–1990 and 1997–1999.

S. S. Soedamah-Muthu, H. M. Colhoun, H. Abrahamian, N. N. Chan, R. Mangili… in Diabetologia (2002)

Article

Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB Prospective Complications Study

Proliferative diabetic retinopathy (PDR), a leading cause of blindness, cannot be totally prevented by optimizing metabolic and blood pressure control and responds to no specific treatment other than partiall...

M. Porta, A.-K. Sjoelie, N. Chaturvedi, L. Stevens, R. Rottiers, M. Veglio… in Diabetologia (2001)

Article

Increased urinary albumin excretion and its associations in the WHO Multinational Study of Vascular Disease in Diabetes

We aimed to determine variations in the prevalence of increased urinary albumin excretion, associated risk factors and complications in patients with diabetes participating in the WHO Multinational Study of V...

P. H. Bennett, E. T. Lee, M. Lu, H. Keen, J. H. Fuller in Diabetologia (2001)

Article

Mortality and causes of death in the WHO multinational study of vascular disease in diabetes

We aimed to examine the mortality rates, excess mortality and causes of death in diabetic patients from ten centres throughout the world.

N. J. Morrish, S.-L. Wang, L. K. Stevens, J. H. Fuller, H. Keen in Diabetologia (2001)

Article

Risk factors for renal failure: The WHO multinational study of vascular disease in diabetes

We aimed to examine risk factors for, and differences in, renal failure in diabetic patients from 10 centres.

H. M. Colhoun, E. T. Lee, P. H. Bennett, M. Lu, H. Keen, S-L. Wang… in Diabetologia (2001)

Article

Follow-up of the WHO multinational study of vascular disease in diabetes: general description and morbidity

The incidence of retinal, renal and cardiovascular complications and their relation to baseline risk factors was documented in this follow-up study of 10 of the 14 original centres of the WHO Multinational St...

E. T. Lee, H. Keen, P. H. Bennett, J. H. Fuller, M. Lu in Diabetologia (2001)